These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 24967926

  • 21. Glial cell line-derived neurotrophic factor prevents death, but not reductions in tyrosine hydroxylase, of injured nigrostriatal neurons in adult rats.
    Lu X, Hagg T.
    J Comp Neurol; 1997 Nov 24; 388(3):484-94. PubMed ID: 9368855
    [Abstract] [Full Text] [Related]

  • 22. Neuroprotective effects of Aceglutamide on motor function in a rat model of cerebral ischemia and reperfusion.
    Zhang R, Yang N, Ji C, Zheng J, Liang Z, Hou CY, Liu YY, Zuo PP.
    Restor Neurol Neurosci; 2015 Nov 24; 33(5):741-59. PubMed ID: 26444640
    [Abstract] [Full Text] [Related]

  • 23. Neuroprotective effect of tyrosol on transient focal cerebral ischemia in rats.
    Bu Y, Rho S, Kim J, Kim MY, Lee DH, Kim SY, Choi H, Kim H.
    Neurosci Lett; 2007 Mar 13; 414(3):218-21. PubMed ID: 17316989
    [Abstract] [Full Text] [Related]

  • 24. Neuroprotective effect of nobiletin on cerebral ischemia-reperfusion injury in transient middle cerebral artery-occluded rats.
    Yasuda N, Ishii T, Oyama D, Fukuta T, Agato Y, Sato A, Shimizu K, Asai T, Asakawa T, Kan T, Yamada S, Ohizumi Y, Oku N.
    Brain Res; 2014 Apr 22; 1559():46-54. PubMed ID: 24534366
    [Abstract] [Full Text] [Related]

  • 25. Neuroprotective effects of melatonin on the nigrostriatal dopamine system in the zitter rat.
    Hashimoto K, Ueda S, Ehara A, Sakakibara S, Yoshimoto K, Hirata K.
    Neurosci Lett; 2012 Jan 06; 506(1):79-83. PubMed ID: 22056485
    [Abstract] [Full Text] [Related]

  • 26. p120 catenin/αN-catenin are molecular targets in the neuroprotection and neuronal plasticity mediated by atorvastatin after focal cerebral ischemia.
    Céspedes-Rubio A, Jurado FW, Cardona-Gómez GP.
    J Neurosci Res; 2010 Dec 06; 88(16):3621-34. PubMed ID: 20936696
    [Abstract] [Full Text] [Related]

  • 27. Extrapyramidal motor symptoms versus striatal infarction volume after focal ischemia in mongolian gerbils.
    Ishibashi S, Kuroiwa T, Katsumata N, Yuan SL, Endo S, Mizusawa H.
    Neuroscience; 2004 Dec 06; 127(2):269-75. PubMed ID: 15262318
    [Abstract] [Full Text] [Related]

  • 28. The intrastriatal injection of thrombin in rat induced a retrograde apoptotic degeneration of nigral dopaminergic neurons through synaptic elimination.
    Herrera AJ, de Pablos RM, Carreño-Müller E, Villarán RF, Venero JL, Tomás-Camardiel M, Cano J, Machado A.
    J Neurochem; 2008 May 06; 105(3):750-62. PubMed ID: 18179476
    [Abstract] [Full Text] [Related]

  • 29. Vasoactive intestinal peptide enhances striatal plasticity and prevents dopaminergic cell loss in Parkinsonian rats.
    Korkmaz O, Ay H, Ulupinar E, Tunçel N.
    J Mol Neurosci; 2012 Nov 06; 48(3):565-73. PubMed ID: 22544516
    [Abstract] [Full Text] [Related]

  • 30. Effects of nigrostriatal lesions on the levels of messenger RNAs encoding two isoforms of glutamate decarboxylase in the globus pallidus and entopeduncular nucleus of the rat.
    Soghomonian JJ, Chesselet MF.
    Synapse; 1992 Jun 06; 11(2):124-33. PubMed ID: 1626311
    [Abstract] [Full Text] [Related]

  • 31. Effects of isradipine, an L-type calcium channel blocker on permanent and transient focal cerebral ischemia in spontaneously hypertensive rats.
    Campbell CA, Mackay KB, Patel S, King PD, Stretton JL, Hadingham SJ, Hamilton TC.
    Exp Neurol; 1997 Nov 06; 148(1):45-50. PubMed ID: 9398449
    [Abstract] [Full Text] [Related]

  • 32. Beneficial effect of agmatine on brain apoptosis, astrogliosis, and edema after rat transient cerebral ischemia.
    Wang CC, Chio CC, Chang CH, Kuo JR, Chang CP.
    BMC Pharmacol; 2010 Sep 06; 10():11. PubMed ID: 20815926
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Intracerebroventricular injection of human prostatic acid phosphatase has potent neuroprotective effects against transient focal cerebral ischemia in rats.
    Yang Y, Bai X, Dong H, Lu Y, Xiong L.
    Neurosci Lett; 2011 Oct 31; 504(3):321-4. PubMed ID: 21982807
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. The antioxidant drink effective microorganism-X (EM-X) pre-treatment attenuates the loss of nigrostriatal dopaminergic neurons in 6-hydroxydopamine-lesion rat model of Parkinson's disease.
    Datla KP, Bennett RD, Zbarsky V, Ke B, Liang YF, Higa T, Bahorun T, Aruoma OI, Dexter DT.
    J Pharm Pharmacol; 2004 May 31; 56(5):649-54. PubMed ID: 15142343
    [Abstract] [Full Text] [Related]

  • 39. Rosiglitazone, a PPAR-γ agonist, protects against striatal dopaminergic neurodegeneration induced by 6-OHDA lesions in the substantia nigra of rats.
    Lee EY, Lee JE, Park JH, Shin IC, Koh HC.
    Toxicol Lett; 2012 Sep 18; 213(3):332-44. PubMed ID: 22842585
    [Abstract] [Full Text] [Related]

  • 40. Glial cell line-derived neurotrophic factor (GDNF) gene delivery protects dopaminergic terminals from degeneration.
    Connor B, Kozlowski DA, Unnerstall JR, Elsworth JD, Tillerson JL, Schallert T, Bohn MC.
    Exp Neurol; 2001 May 18; 169(1):83-95. PubMed ID: 11312561
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.